down arrow

Jiangsu Kanion Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001CL7
CNY
15.10
0.00 (0.00%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jiangsu Kanion Pharmaceutical Co., Ltd.
Why is Jiangsu Kanion Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.17% and Operating profit at -17.80% over the last 5 years
2
With a fall in Net Sales of -14.97%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 2 consecutive quarters
  • INTEREST(9M) At CNY 25.35 MM has Grown at inf%
  • NET SALES(Q) At CNY 861.48 MM has Fallen at -35.59%
  • OPERATING CASH FLOW(Y) Lowest at CNY 596.24 MM
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 0.94% in the last 1 year, much lower than market (China Shanghai Composite) returns of 14.77%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Kanion Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Jiangsu Kanion Pharmaceutical Co., Ltd.
0.94%
-0.35
35.12%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-3.17%
EBIT Growth (5y)
-17.80%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.84
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.05%
ROE (avg)
8.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.86
EV to EBIT
37.81
EV to EBITDA
18.11
EV to Capital Employed
2.26
EV to Sales
2.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.98%
ROE (Latest)
5.55%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 0.68% (YoY

-32What is not working for the Company
INTEREST(9M)

At CNY 25.35 MM has Grown at inf%

NET SALES(Q)

At CNY 861.48 MM has Fallen at -35.59%

OPERATING CASH FLOW(Y)

Lowest at CNY 596.24 MM

ROCE(HY)

Lowest at 6.59%

PRE-TAX PROFIT(Q)

At CNY 103.79 MM has Fallen at -41.56%

NET PROFIT(Q)

At CNY 83.41 MM has Fallen at -43.66%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.19%

Here's what is working for Jiangsu Kanion Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by 0.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangsu Kanion Pharmaceutical Co., Ltd.
Interest
At CNY 25.35 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 861.48 MM has Fallen at -35.59%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 103.79 MM has Fallen at -41.56%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 83.41 MM has Fallen at -43.66%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 596.24 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio
Lowest at 2.19%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."